Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Name | miRBASE accession |
---|---|
hsa-miR-130a-3p
|
MIMAT0000425 |
hsa-miR-130b-3p
|
MIMAT0000691 |
hsa-miR-301a-3p
|
MIMAT0000688 |
hsa-miR-301b-3p
|
MIMAT0004958 |
hsa-miR-454-3p
|
MIMAT0003885 |
hsa-miR-3666
|
MIMAT0018088 |
hsa-miR-4295
|
MIMAT0016844 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_145567173 | 2.20 |
ENST00000296575.3 |
HHIP |
hedgehog interacting protein |
chr5_+_71403061 | 2.03 |
ENST00000512974.1 ENST00000296755.7 |
MAP1B |
microtubule-associated protein 1B |
chr14_-_60097297 | 1.79 |
ENST00000395090.1 |
RTN1 |
reticulon 1 |
chr10_+_31608054 | 1.78 |
ENST00000320985.10 ENST00000361642.5 ENST00000560721.2 ENST00000558440.1 ENST00000424869.1 ENST00000542815.3 |
ZEB1 |
zinc finger E-box binding homeobox 1 |
chr5_+_75699040 | 1.59 |
ENST00000274364.6 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
chr11_+_113930291 | 1.58 |
ENST00000335953.4 |
ZBTB16 |
zinc finger and BTB domain containing 16 |
chr21_-_39288743 | 1.16 |
ENST00000609713.1 |
KCNJ6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
chr11_-_70507901 | 1.16 |
ENST00000449833.2 ENST00000357171.3 ENST00000449116.2 |
SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
chr18_-_65184217 | 1.14 |
ENST00000310045.7 |
DSEL |
dermatan sulfate epimerase-like |
chr3_+_110790590 | 1.11 |
ENST00000485303.1 |
PVRL3 |
poliovirus receptor-related 3 |
chr4_+_55095264 | 1.10 |
ENST00000257290.5 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
chr5_+_172068232 | 1.10 |
ENST00000520919.1 ENST00000522853.1 ENST00000369800.5 |
NEURL1B |
neuralized E3 ubiquitin protein ligase 1B |
chrX_+_66764375 | 0.96 |
ENST00000374690.3 |
AR |
androgen receptor |
chr17_-_76870222 | 0.94 |
ENST00000585421.1 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
chr11_-_74109422 | 0.93 |
ENST00000298198.4 |
PGM2L1 |
phosphoglucomutase 2-like 1 |
chr13_-_33859819 | 0.88 |
ENST00000336934.5 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
chr17_+_47074758 | 0.84 |
ENST00000290341.3 |
IGF2BP1 |
insulin-like growth factor 2 mRNA binding protein 1 |
chr11_-_82782861 | 0.83 |
ENST00000524635.1 ENST00000526205.1 ENST00000527633.1 ENST00000533486.1 ENST00000533276.2 |
RAB30 |
RAB30, member RAS oncogene family |
chr2_+_56411131 | 0.81 |
ENST00000407595.2 |
CCDC85A |
coiled-coil domain containing 85A |
chr5_-_136834982 | 0.81 |
ENST00000510689.1 ENST00000394945.1 |
SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
chr5_-_137368708 | 0.79 |
ENST00000033079.3 |
FAM13B |
family with sequence similarity 13, member B |
chr4_+_15004165 | 0.77 |
ENST00000538197.1 ENST00000541112.1 ENST00000442003.2 |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
chr8_+_70378852 | 0.77 |
ENST00000525061.1 ENST00000458141.2 ENST00000260128.4 |
SULF1 |
sulfatase 1 |
chr10_-_81205373 | 0.74 |
ENST00000372336.3 |
ZCCHC24 |
zinc finger, CCHC domain containing 24 |
chr2_-_101767715 | 0.73 |
ENST00000376840.4 ENST00000409318.1 |
TBC1D8 |
TBC1 domain family, member 8 (with GRAM domain) |
chr6_+_136172820 | 0.72 |
ENST00000308191.6 |
PDE7B |
phosphodiesterase 7B |
chr12_-_92539614 | 0.69 |
ENST00000256015.3 |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
chr8_-_23712312 | 0.69 |
ENST00000290271.2 |
STC1 |
stanniocalcin 1 |
chr15_-_49338748 | 0.64 |
ENST00000559471.1 |
SECISBP2L |
SECIS binding protein 2-like |
chr13_+_93879085 | 0.64 |
ENST00000377047.4 |
GPC6 |
glypican 6 |
chr3_-_66551351 | 0.62 |
ENST00000273261.3 |
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
chr3_-_114790179 | 0.61 |
ENST00000462705.1 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr1_+_145438469 | 0.59 |
ENST00000369317.4 |
TXNIP |
thioredoxin interacting protein |
chr20_-_48099182 | 0.58 |
ENST00000371741.4 |
KCNB1 |
potassium voltage-gated channel, Shab-related subfamily, member 1 |
chr10_-_33623564 | 0.58 |
ENST00000374875.1 ENST00000374822.4 |
NRP1 |
neuropilin 1 |
chr3_-_178790057 | 0.57 |
ENST00000311417.2 |
ZMAT3 |
zinc finger, matrin-type 3 |
chr8_+_17013515 | 0.57 |
ENST00000262096.8 |
ZDHHC2 |
zinc finger, DHHC-type containing 2 |
chr21_+_45285050 | 0.57 |
ENST00000291572.8 |
AGPAT3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr8_+_38614807 | 0.55 |
ENST00000330691.6 ENST00000348567.4 |
TACC1 |
transforming, acidic coiled-coil containing protein 1 |
chr2_-_180129484 | 0.52 |
ENST00000428443.3 |
SESTD1 |
SEC14 and spectrin domains 1 |
chr20_+_34700333 | 0.51 |
ENST00000441639.1 |
EPB41L1 |
erythrocyte membrane protein band 4.1-like 1 |
chr14_-_53417732 | 0.51 |
ENST00000399304.3 ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2 |
fermitin family member 2 |
chr5_-_90679145 | 0.51 |
ENST00000265138.3 |
ARRDC3 |
arrestin domain containing 3 |
chr2_-_200322723 | 0.50 |
ENST00000417098.1 |
SATB2 |
SATB homeobox 2 |
chr9_-_79520989 | 0.49 |
ENST00000376713.3 ENST00000376718.3 ENST00000428286.1 |
PRUNE2 |
prune homolog 2 (Drosophila) |
chr5_+_173315283 | 0.49 |
ENST00000265085.5 |
CPEB4 |
cytoplasmic polyadenylation element binding protein 4 |
chr8_-_93115445 | 0.48 |
ENST00000523629.1 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr3_+_194406603 | 0.47 |
ENST00000329759.4 |
FAM43A |
family with sequence similarity 43, member A |
chr3_+_197687071 | 0.47 |
ENST00000482695.1 ENST00000330198.4 ENST00000419117.1 ENST00000420910.2 ENST00000332636.5 |
LMLN |
leishmanolysin-like (metallopeptidase M8 family) |
chr4_+_129730779 | 0.47 |
ENST00000226319.6 |
PHF17 |
jade family PHD finger 1 |
chr2_+_46926048 | 0.43 |
ENST00000306503.5 |
SOCS5 |
suppressor of cytokine signaling 5 |
chr10_+_92980517 | 0.43 |
ENST00000336126.5 |
PCGF5 |
polycomb group ring finger 5 |
chr6_-_88876058 | 0.43 |
ENST00000369501.2 |
CNR1 |
cannabinoid receptor 1 (brain) |
chr5_-_138210977 | 0.42 |
ENST00000274711.6 ENST00000521094.2 |
LRRTM2 |
leucine rich repeat transmembrane neuronal 2 |
chr8_-_67525473 | 0.42 |
ENST00000522677.3 |
MYBL1 |
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
chr12_-_53893399 | 0.42 |
ENST00000267079.2 |
MAP3K12 |
mitogen-activated protein kinase kinase kinase 12 |
chr5_-_131826457 | 0.42 |
ENST00000437654.1 ENST00000245414.4 |
IRF1 |
interferon regulatory factor 1 |
chr8_-_13372395 | 0.41 |
ENST00000276297.4 ENST00000511869.1 |
DLC1 |
deleted in liver cancer 1 |
chr14_+_52118576 | 0.41 |
ENST00000395718.2 ENST00000344768.5 |
FRMD6 |
FERM domain containing 6 |
chr10_+_63661053 | 0.40 |
ENST00000279873.7 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
chr20_-_56284816 | 0.40 |
ENST00000395819.3 ENST00000341744.3 |
PMEPA1 |
prostate transmembrane protein, androgen induced 1 |
chr4_-_185747188 | 0.40 |
ENST00000507295.1 ENST00000504900.1 ENST00000281455.2 ENST00000454703.2 |
ACSL1 |
acyl-CoA synthetase long-chain family member 1 |
chr8_+_26435359 | 0.39 |
ENST00000311151.5 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr10_-_128077024 | 0.39 |
ENST00000368679.4 ENST00000368676.4 ENST00000448723.1 |
ADAM12 |
ADAM metallopeptidase domain 12 |
chr21_+_39628655 | 0.38 |
ENST00000398925.1 ENST00000398928.1 ENST00000328656.4 ENST00000443341.1 |
KCNJ15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr15_-_83316254 | 0.38 |
ENST00000567678.1 ENST00000450751.2 |
CPEB1 |
cytoplasmic polyadenylation element binding protein 1 |
chr14_-_75593708 | 0.37 |
ENST00000557673.1 ENST00000238616.5 |
NEK9 |
NIMA-related kinase 9 |
chr7_-_152133059 | 0.37 |
ENST00000262189.6 ENST00000355193.2 |
KMT2C |
lysine (K)-specific methyltransferase 2C |
chr17_-_78450398 | 0.37 |
ENST00000306773.4 |
NPTX1 |
neuronal pentraxin I |
chr1_-_225840747 | 0.37 |
ENST00000366843.2 ENST00000366844.3 |
ENAH |
enabled homolog (Drosophila) |
chr12_+_120105558 | 0.36 |
ENST00000229328.5 ENST00000541640.1 |
PRKAB1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
chr5_-_107006596 | 0.36 |
ENST00000333274.6 |
EFNA5 |
ephrin-A5 |
chr5_-_65017921 | 0.34 |
ENST00000381007.4 |
SGTB |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
chr5_-_133968529 | 0.34 |
ENST00000402673.2 |
SAR1B |
SAR1 homolog B (S. cerevisiae) |
chr3_+_179370517 | 0.34 |
ENST00000263966.3 |
USP13 |
ubiquitin specific peptidase 13 (isopeptidase T-3) |
chr7_+_29603394 | 0.34 |
ENST00000319694.2 |
PRR15 |
proline rich 15 |
chr7_-_27183263 | 0.33 |
ENST00000222726.3 |
HOXA5 |
homeobox A5 |
chr6_-_111136513 | 0.33 |
ENST00000368911.3 |
CDK19 |
cyclin-dependent kinase 19 |
chrX_-_103087136 | 0.32 |
ENST00000243298.2 |
RAB9B |
RAB9B, member RAS oncogene family |
chr8_-_116681221 | 0.32 |
ENST00000395715.3 |
TRPS1 |
trichorhinophalangeal syndrome I |
chr10_-_102279586 | 0.32 |
ENST00000370345.3 ENST00000451524.1 ENST00000370329.5 |
SEC31B |
SEC31 homolog B (S. cerevisiae) |
chr2_-_182545603 | 0.31 |
ENST00000295108.3 |
NEUROD1 |
neuronal differentiation 1 |
chr18_-_30050395 | 0.31 |
ENST00000269209.6 ENST00000399218.4 |
GAREM |
GRB2 associated, regulator of MAPK1 |
chr16_-_77468945 | 0.31 |
ENST00000282849.5 |
ADAMTS18 |
ADAM metallopeptidase with thrombospondin type 1 motif, 18 |
chr3_-_15901278 | 0.30 |
ENST00000399451.2 |
ANKRD28 |
ankyrin repeat domain 28 |
chr2_-_40679186 | 0.29 |
ENST00000406785.2 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr8_-_92053212 | 0.28 |
ENST00000285419.3 |
TMEM55A |
transmembrane protein 55A |
chrX_-_92928557 | 0.28 |
ENST00000373079.3 ENST00000475430.2 |
NAP1L3 |
nucleosome assembly protein 1-like 3 |
chr20_-_5591626 | 0.28 |
ENST00000379019.4 |
GPCPD1 |
glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) |
chr5_+_125935960 | 0.28 |
ENST00000297540.4 |
PHAX |
phosphorylated adaptor for RNA export |
chr8_-_12612962 | 0.28 |
ENST00000398246.3 |
LONRF1 |
LON peptidase N-terminal domain and ring finger 1 |
chr18_+_72922710 | 0.28 |
ENST00000322038.5 |
TSHZ1 |
teashirt zinc finger homeobox 1 |
chr11_+_27015628 | 0.27 |
ENST00000318627.2 |
FIBIN |
fin bud initiation factor homolog (zebrafish) |
chr3_+_57261743 | 0.27 |
ENST00000288266.3 |
APPL1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
chr20_+_11871371 | 0.27 |
ENST00000254977.3 |
BTBD3 |
BTB (POZ) domain containing 3 |
chr12_+_108908962 | 0.27 |
ENST00000552695.1 ENST00000552758.1 ENST00000361549.2 |
FICD |
FIC domain containing |
chrX_-_18372792 | 0.27 |
ENST00000251900.4 |
SCML2 |
sex comb on midleg-like 2 (Drosophila) |
chr1_+_78245303 | 0.27 |
ENST00000370791.3 ENST00000443751.2 |
FAM73A |
family with sequence similarity 73, member A |
chr5_-_59189545 | 0.27 |
ENST00000340635.6 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
chr10_-_27529716 | 0.27 |
ENST00000375897.3 ENST00000396271.3 |
ACBD5 |
acyl-CoA binding domain containing 5 |
chr16_+_21169976 | 0.26 |
ENST00000572258.1 ENST00000261388.3 ENST00000451578.2 ENST00000572599.1 ENST00000577162.1 |
TMEM159 |
transmembrane protein 159 |
chr12_+_56367697 | 0.26 |
ENST00000553116.1 ENST00000360299.5 ENST00000548068.1 ENST00000549915.1 ENST00000551459.1 ENST00000448789.2 |
RAB5B |
RAB5B, member RAS oncogene family |
chr1_+_218519577 | 0.26 |
ENST00000366930.4 ENST00000366929.4 |
TGFB2 |
transforming growth factor, beta 2 |
chr4_+_55524085 | 0.25 |
ENST00000412167.2 ENST00000288135.5 |
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr3_-_141868357 | 0.25 |
ENST00000489671.1 ENST00000475734.1 ENST00000467072.1 ENST00000499676.2 |
TFDP2 |
transcription factor Dp-2 (E2F dimerization partner 2) |
chr1_+_97187318 | 0.25 |
ENST00000609116.1 ENST00000370198.1 ENST00000370197.1 ENST00000426398.2 ENST00000394184.3 |
PTBP2 |
polypyrimidine tract binding protein 2 |
chr15_-_68724490 | 0.25 |
ENST00000315757.7 ENST00000423218.2 |
ITGA11 |
integrin, alpha 11 |
chr20_+_46130601 | 0.24 |
ENST00000341724.6 |
NCOA3 |
nuclear receptor coactivator 3 |
chr1_+_154975110 | 0.24 |
ENST00000535420.1 ENST00000368426.3 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
chr9_+_99212403 | 0.24 |
ENST00000375251.3 ENST00000375249.4 |
HABP4 |
hyaluronan binding protein 4 |
chrX_+_118108571 | 0.24 |
ENST00000304778.7 |
LONRF3 |
LON peptidase N-terminal domain and ring finger 3 |
chr5_+_135468516 | 0.24 |
ENST00000507118.1 ENST00000511116.1 ENST00000545279.1 ENST00000545620.1 |
SMAD5 |
SMAD family member 5 |
chr17_+_65821780 | 0.24 |
ENST00000321892.4 ENST00000335221.5 ENST00000306378.6 |
BPTF |
bromodomain PHD finger transcription factor |
chr5_+_138940742 | 0.24 |
ENST00000398733.3 ENST00000253815.2 ENST00000505007.1 |
UBE2D2 |
ubiquitin-conjugating enzyme E2D 2 |
chr3_-_64211112 | 0.24 |
ENST00000295902.6 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
chr16_+_50775948 | 0.24 |
ENST00000569681.1 ENST00000569418.1 ENST00000540145.1 |
CYLD |
cylindromatosis (turban tumor syndrome) |
chr4_-_85887503 | 0.24 |
ENST00000509172.1 ENST00000322366.6 ENST00000295888.4 ENST00000502713.1 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
chr22_+_50781723 | 0.23 |
ENST00000359139.3 ENST00000395741.3 ENST00000395744.3 |
PPP6R2 |
protein phosphatase 6, regulatory subunit 2 |
chr19_-_10341948 | 0.23 |
ENST00000590320.1 ENST00000592342.1 ENST00000588952.1 |
S1PR2 DNMT1 |
sphingosine-1-phosphate receptor 2 DNA (cytosine-5-)-methyltransferase 1 |
chr17_+_27717415 | 0.23 |
ENST00000583121.1 ENST00000261716.3 |
TAOK1 |
TAO kinase 1 |
chr11_+_67806467 | 0.23 |
ENST00000265686.3 ENST00000524598.1 ENST00000529657.1 |
TCIRG1 |
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
chrX_+_53111541 | 0.23 |
ENST00000375442.4 ENST00000579390.1 |
TSPYL2 |
TSPY-like 2 |
chr10_-_104178857 | 0.23 |
ENST00000020673.5 |
PSD |
pleckstrin and Sec7 domain containing |
chr8_+_11141925 | 0.23 |
ENST00000221086.3 |
MTMR9 |
myotubularin related protein 9 |
chr3_-_124774802 | 0.23 |
ENST00000311127.4 |
HEG1 |
heart development protein with EGF-like domains 1 |
chr10_-_32636106 | 0.22 |
ENST00000263062.8 ENST00000319778.6 |
EPC1 |
enhancer of polycomb homolog 1 (Drosophila) |
chr18_+_9136758 | 0.22 |
ENST00000383440.2 ENST00000262126.4 ENST00000577992.1 |
ANKRD12 |
ankyrin repeat domain 12 |
chr2_+_24714729 | 0.22 |
ENST00000406961.1 ENST00000405141.1 |
NCOA1 |
nuclear receptor coactivator 1 |
chr2_+_121103706 | 0.22 |
ENST00000295228.3 |
INHBB |
inhibin, beta B |
chr2_+_173940442 | 0.22 |
ENST00000409176.2 ENST00000338983.3 ENST00000431503.2 |
MLTK |
Mitogen-activated protein kinase kinase kinase MLT |
chrX_+_72783026 | 0.22 |
ENST00000373504.6 ENST00000373502.5 |
CHIC1 |
cysteine-rich hydrophobic domain 1 |
chr10_+_20105157 | 0.22 |
ENST00000377242.3 ENST00000377252.4 |
PLXDC2 |
plexin domain containing 2 |
chr13_-_107187462 | 0.21 |
ENST00000245323.4 |
EFNB2 |
ephrin-B2 |
chr3_+_5020801 | 0.21 |
ENST00000256495.3 |
BHLHE40 |
basic helix-loop-helix family, member e40 |
chr14_-_96830207 | 0.21 |
ENST00000359933.4 |
ATG2B |
autophagy related 2B |
chr20_+_32399093 | 0.20 |
ENST00000217402.2 |
CHMP4B |
charged multivesicular body protein 4B |
chr1_+_12290121 | 0.20 |
ENST00000358136.3 ENST00000356315.4 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr6_+_168841817 | 0.20 |
ENST00000356284.2 ENST00000354536.5 |
SMOC2 |
SPARC related modular calcium binding 2 |
chr1_-_214724566 | 0.20 |
ENST00000366956.5 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
chr5_-_133512683 | 0.20 |
ENST00000353411.6 |
SKP1 |
S-phase kinase-associated protein 1 |
chr4_-_175750364 | 0.20 |
ENST00000340217.5 ENST00000274093.3 |
GLRA3 |
glycine receptor, alpha 3 |
chr14_-_35182994 | 0.20 |
ENST00000341223.3 |
CFL2 |
cofilin 2 (muscle) |
chr3_-_190580404 | 0.20 |
ENST00000442080.1 |
GMNC |
geminin coiled-coil domain containing |
chr11_+_120894781 | 0.20 |
ENST00000529397.1 ENST00000528512.1 ENST00000422003.2 |
TBCEL |
tubulin folding cofactor E-like |
chr3_+_152017181 | 0.20 |
ENST00000498502.1 ENST00000324196.5 ENST00000545754.1 ENST00000357472.3 |
MBNL1 |
muscleblind-like splicing regulator 1 |
chr14_+_74111578 | 0.19 |
ENST00000554113.1 ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1 |
dynein, axonemal, light chain 1 |
chr2_-_158485387 | 0.19 |
ENST00000243349.8 |
ACVR1C |
activin A receptor, type IC |
chr12_-_118541743 | 0.19 |
ENST00000359236.5 |
VSIG10 |
V-set and immunoglobulin domain containing 10 |
chr1_+_36396677 | 0.19 |
ENST00000373191.4 ENST00000397828.2 |
AGO3 |
argonaute RISC catalytic component 3 |
chr3_+_50712672 | 0.18 |
ENST00000266037.9 |
DOCK3 |
dedicator of cytokinesis 3 |
chr2_-_86948245 | 0.18 |
ENST00000439940.2 ENST00000604011.1 |
CHMP3 RNF103-CHMP3 |
charged multivesicular body protein 3 RNF103-CHMP3 readthrough |
chr2_-_11484710 | 0.18 |
ENST00000315872.6 |
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
chr15_+_38544476 | 0.18 |
ENST00000299084.4 |
SPRED1 |
sprouty-related, EVH1 domain containing 1 |
chr9_+_100263912 | 0.18 |
ENST00000259365.4 |
TMOD1 |
tropomodulin 1 |
chr3_-_18466787 | 0.18 |
ENST00000338745.6 ENST00000450898.1 |
SATB1 |
SATB homeobox 1 |
chr11_+_120207787 | 0.18 |
ENST00000397843.2 ENST00000356641.3 |
ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
chr19_+_47421933 | 0.18 |
ENST00000404338.3 |
ARHGAP35 |
Rho GTPase activating protein 35 |
chr17_-_40540377 | 0.18 |
ENST00000404395.3 ENST00000389272.3 ENST00000585517.1 ENST00000588065.1 |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
chr17_-_62340581 | 0.17 |
ENST00000258991.3 ENST00000583738.1 ENST00000584379.1 |
TEX2 |
testis expressed 2 |
chr14_-_104029013 | 0.17 |
ENST00000299204.4 ENST00000557666.1 |
BAG5 |
BCL2-associated athanogene 5 |
chr7_-_105517021 | 0.17 |
ENST00000318724.4 ENST00000419735.3 |
ATXN7L1 |
ataxin 7-like 1 |
chr7_+_106809406 | 0.17 |
ENST00000468410.1 ENST00000478930.1 ENST00000464009.1 ENST00000222574.4 |
HBP1 |
HMG-box transcription factor 1 |
chr12_+_104458235 | 0.17 |
ENST00000229330.4 |
HCFC2 |
host cell factor C2 |
chr1_+_193091080 | 0.17 |
ENST00000367435.3 |
CDC73 |
cell division cycle 73 |
chr11_-_108093329 | 0.17 |
ENST00000278612.8 |
NPAT |
nuclear protein, ataxia-telangiectasia locus |
chr11_-_10315741 | 0.17 |
ENST00000256190.8 |
SBF2 |
SET binding factor 2 |
chr6_+_157802165 | 0.17 |
ENST00000414563.2 ENST00000359775.5 |
ZDHHC14 |
zinc finger, DHHC-type containing 14 |
chr8_-_30891078 | 0.17 |
ENST00000339382.2 ENST00000475541.1 |
PURG |
purine-rich element binding protein G |
chr11_+_109964087 | 0.17 |
ENST00000278590.3 |
ZC3H12C |
zinc finger CCCH-type containing 12C |
chr13_+_49822041 | 0.17 |
ENST00000538056.1 ENST00000251108.6 ENST00000444959.1 ENST00000429346.1 |
CDADC1 |
cytidine and dCMP deaminase domain containing 1 |
chr2_-_2334888 | 0.17 |
ENST00000428368.2 ENST00000399161.2 |
MYT1L |
myelin transcription factor 1-like |
chr1_+_84543734 | 0.17 |
ENST00000370689.2 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chr18_+_67956135 | 0.17 |
ENST00000397942.3 |
SOCS6 |
suppressor of cytokine signaling 6 |
chrX_-_118284542 | 0.16 |
ENST00000402510.2 |
KIAA1210 |
KIAA1210 |
chr16_-_20911641 | 0.16 |
ENST00000564349.1 ENST00000324344.4 |
ERI2 DCUN1D3 |
ERI1 exoribonuclease family member 2 DCN1, defective in cullin neddylation 1, domain containing 3 |
chr4_+_75230853 | 0.16 |
ENST00000244869.2 |
EREG |
epiregulin |
chr1_-_52831796 | 0.16 |
ENST00000284376.3 ENST00000438831.1 ENST00000371586.2 |
CC2D1B |
coiled-coil and C2 domain containing 1B |
chr1_+_11866207 | 0.16 |
ENST00000312413.6 ENST00000346436.6 |
CLCN6 |
chloride channel, voltage-sensitive 6 |
chr19_+_3359561 | 0.16 |
ENST00000589123.1 ENST00000346156.5 ENST00000395111.3 ENST00000586919.1 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
chr2_+_203879568 | 0.16 |
ENST00000449802.1 |
NBEAL1 |
neurobeachin-like 1 |
chr7_+_116312411 | 0.15 |
ENST00000456159.1 ENST00000397752.3 ENST00000318493.6 |
MET |
met proto-oncogene |
chr2_+_120517174 | 0.15 |
ENST00000263708.2 |
PTPN4 |
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
chr14_-_57735528 | 0.15 |
ENST00000340918.7 ENST00000413566.2 |
EXOC5 |
exocyst complex component 5 |
chr12_-_82153087 | 0.15 |
ENST00000547623.1 ENST00000549396.1 |
PPFIA2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
chr3_-_72496035 | 0.15 |
ENST00000477973.2 |
RYBP |
RING1 and YY1 binding protein |
chr2_-_86564776 | 0.15 |
ENST00000165698.5 ENST00000541910.1 ENST00000535845.1 |
REEP1 |
receptor accessory protein 1 |
chr1_+_162467595 | 0.15 |
ENST00000538489.1 ENST00000489294.1 |
UHMK1 |
U2AF homology motif (UHM) kinase 1 |
chr2_+_30670077 | 0.15 |
ENST00000466477.1 ENST00000465200.1 ENST00000379509.3 ENST00000319406.4 ENST00000488144.1 ENST00000465538.1 ENST00000309052.4 ENST00000359433.1 |
LCLAT1 |
lysocardiolipin acyltransferase 1 |
chr5_+_80256453 | 0.15 |
ENST00000265080.4 |
RASGRF2 |
Ras protein-specific guanine nucleotide-releasing factor 2 |
chr5_-_134871639 | 0.15 |
ENST00000314744.4 |
NEUROG1 |
neurogenin 1 |
chr22_-_36236265 | 0.14 |
ENST00000414461.2 ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr9_+_108006880 | 0.14 |
ENST00000374723.1 ENST00000374720.3 ENST00000374724.1 |
SLC44A1 |
solute carrier family 44 (choline transporter), member 1 |
chr5_-_56247935 | 0.14 |
ENST00000381199.3 ENST00000381226.3 ENST00000381213.3 |
MIER3 |
mesoderm induction early response 1, family member 3 |
chr18_-_44702668 | 0.14 |
ENST00000256433.3 |
IER3IP1 |
immediate early response 3 interacting protein 1 |
chr6_+_56954867 | 0.14 |
ENST00000370708.4 ENST00000370702.1 |
ZNF451 |
zinc finger protein 451 |
chr1_+_173684047 | 0.14 |
ENST00000546011.1 ENST00000209884.4 |
KLHL20 |
kelch-like family member 20 |
chr20_-_32308028 | 0.14 |
ENST00000409299.3 ENST00000217398.3 ENST00000344022.3 |
PXMP4 |
peroxisomal membrane protein 4, 24kDa |
chr14_-_20929624 | 0.14 |
ENST00000398020.4 ENST00000250489.4 |
TMEM55B |
transmembrane protein 55B |
chr13_-_79177673 | 0.14 |
ENST00000377208.5 |
POU4F1 |
POU class 4 homeobox 1 |
chr4_-_163085141 | 0.14 |
ENST00000427802.2 ENST00000306100.5 |
FSTL5 |
follistatin-like 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.6 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 1.0 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
0.3 | 1.1 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 1.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 1.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.8 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 1.0 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 0.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.3 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.1 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 1.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.6 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.1 | 2.0 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.4 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.4 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.1 | 0.3 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.3 | GO:0038162 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 1.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.3 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.1 | 0.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 1.9 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.4 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.2 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0048880 | epithalamus development(GO:0021538) habenula development(GO:0021986) sensory system development(GO:0048880) |
0.0 | 0.1 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.0 | 0.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.0 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.1 | GO:0043622 | cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
0.0 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.0 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) osteoblast fate commitment(GO:0002051) |
0.0 | 0.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.0 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.0 | 0.1 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.0 | 0.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.0 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) |
0.0 | 0.1 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
0.0 | 1.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.2 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) |
0.0 | 0.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 1.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.1 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.0 | 0.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 0.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.1 | GO:2000820 | pathogenesis(GO:0009405) negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.0 | 0.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.1 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.0 | 0.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.5 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.0 | 0.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.1 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.0 | 0.1 | GO:0042426 | choline catabolic process(GO:0042426) |
0.0 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.2 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.2 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.0 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.0 | 0.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.2 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.2 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.7 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.4 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.2 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.1 | 0.2 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 2.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 1.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 2.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.0 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 1.1 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 1.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 1.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 1.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 1.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 1.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 1.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 1.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.6 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 1.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.0 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.0 | 0.1 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 1.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |